Nascent Pharma Holdings Statistics
Want to see NASC full AI Analyst Report?
Nascent Pharma Holdings (NASC) Stock Statistics & Valuation Metrics
Total Valuation
Nascent Pharma Holdings has a market cap or net worth of $1.68M. The enterprise value is $9.54T.
- Market Cap
- $1.68M
- Enterprise Value
- $9.54T
Share Statistics
Nascent Pharma Holdings has 142,229,160 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 142,229,160
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Nascent Pharma Holdings’s return on equity (ROE) is 0.80 and return on invested capital (ROIC) is 107.66%.
- Return on Equity (ROE)
- 0.80
- Return on Assets (ROA)
- -34.06
- Return on Invested Capital (ROIC)
- 107.66%
- Return on Capital Employed (ROCE)
- 0.37
- Revenue Per Employee
- 0
- Profits Per Employee
- -850.31K
- Employee Count
- 12
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Nascent Pharma Holdings is -0.20. Nascent Pharma Holdings’s PEG ratio is -0.00.
- PE Ratio
- -0.20
- PS Ratio
- 0.00
- PB Ratio
- -0.07
- Price to FCF
- -3.76
- Price to Operating Cash Flow
- -4.24
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Nascent Pharma Holdings had revenue of 0 and earned -10.20M in profits. Earnings per share was -0.17.
- Revenue
- 0
- Gross Profit
- -742.32K
- Operating Income
- -4.76M
- Pretax Income
- -9.78M
- Net Income
- -10.20M
- EBITDA
- -7.65M
- Earnings Per Share (EPS)
- -0.17
Cash Flow
In the last 12 months, operating cash flow was 246.61K and capital expenditures 0, giving a free cash flow of 246.61K billion.
- Operating Cash Flow
- 246.61K
- Free Cash Flow
- 246.61K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Nascent Pharma Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -26.57%
- Earnings Yield
- -508.24%
Stock Price Statistics
- Beta
- -1.66
- 52-Week Price Change
- -35.29%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- 41.31
- Average Volume (3m)
- 64.19K
Financial Position
Nascent Pharma Holdings as a current ratio of 0.02, with Debt / Equity ratio of -65.26%
- Current Ratio
- 0.02
- Quick Ratio
- 0.02
- Debt to Market Cap
- 3.99
- Net Debt to EBITDA
- -1.08
- Interest Coverage Ratio
- -2.68
Taxes
In the past 12 months, Nascent Pharma Holdings has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Nascent Pharma Holdings EV to EBITDA ratio is -3.96, with an EV/FCF ratio of -42.04.
- EV to Sales
- 0.00
- EV to EBITDA
- -3.96
- EV to Free Cash Flow
- -42.04
- EV to Operating Cash Flow
- -42.04
Balance Sheet
Nascent Pharma Holdings has $7,879.00 in cash and marketable securities with $9.01M in debt, giving a net cash position of -$9.01M billion.
- Cash & Marketable Securities
- $7,879.00
- Total Debt
- $9.01M
- Net Cash
- -$9.01M
- Net Cash Per Share
- -$0.06
- Tangible Book Value Per Share
- -$0.15
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Scores
- Smart Score
- ―
- AI Score
- 30.4
